151 related articles for article (PubMed ID: 37531921)
1. Discovery of quinazoline HPK1 inhibitors with high cellular potency.
Toure M; Johnson T; Li B; Schmidt R; Ma H; Neagu C; Lopez AU; Wang Y; Guler S; Xiao Y; Henkes R; Ho K; Zhang S; Chu CL; Gundra UM; Porichis F; Li L; Maurer CK; Fang Z; Musil D; DiPoto M; Friis E; Jones R; Jones C; Cummings J; Chekler E; Tanzer EM; Huck B; Sherer B
Bioorg Med Chem; 2023 Sep; 92():117423. PubMed ID: 37531921
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells.
Brenner D; Brechmann M; Röhling S; Tapernoux M; Mock T; Winter D; Lehmann WD; Kiefer F; Thome M; Krammer PH; Arnold R
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14508-13. PubMed ID: 19706536
[TBL] [Abstract][Full Text] [Related]
3. Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Shi H; Tang H; Li Y; Chen D; Liu T; Chen Y; Wang X; Chen L; Wang Y; Xie H; Xiong B
Eur J Med Chem; 2023 Feb; 248():115064. PubMed ID: 36621137
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes.
Ma W; Xia C; Ling P; Qiu M; Luo Y; Tan TH; Liu M
Oncogene; 2001 Mar; 20(14):1703-14. PubMed ID: 11313918
[TBL] [Abstract][Full Text] [Related]
5. Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling.
Ling P; Meyer CF; Redmond LP; Shui JW; Davis B; Rich RR; Hu MC; Wange RL; Tan TH
J Biol Chem; 2001 Jun; 276(22):18908-14. PubMed ID: 11279207
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 7H-Pyrrolo[2,3-d]pyrimidine Derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Wu F; Li H; An Q; Sun Y; Yu J; Cao W; Sun P; Diao X; Meng L; Xu S
Eur J Med Chem; 2023 Jun; 254():115355. PubMed ID: 37062169
[TBL] [Abstract][Full Text] [Related]
7. Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.
Brenner D; Golks A; Kiefer F; Krammer PH; Arnold R
EMBO J; 2005 Dec; 24(24):4279-90. PubMed ID: 16341093
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.
Vara BA; Levi SM; Achab A; Candito DA; Fradera X; Lesburg CA; Kawamura S; Lacey BM; Lim J; Methot JL; Xu Z; Xu H; Smith DM; Piesvaux JA; Miller JR; Bittinger M; Ranganath SH; Bennett DJ; DiMauro EF; Pasternak A
ACS Med Chem Lett; 2021 Apr; 12(4):653-661. PubMed ID: 33859804
[TBL] [Abstract][Full Text] [Related]
9. Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1.
Zhou L; Ye X; Wang K; Shen H; Wang T; Zhang X; Jiang S; Xiao Y; Zhang K
Bioorg Chem; 2023 Sep; 138():106682. PubMed ID: 37339563
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor.
You D; Hillerman S; Locke G; Chaudhry C; Stromko C; Murtaza A; Fan Y; Koenitzer J; Chen Y; Briceno S; Bhadra R; Duperret E; Gullo-Brown J; Gao C; Zhao D; Feder J; Curtin J; Degnan AP; Kumi G; Wittman M; Johnson BM; Parrish KE; Gokulrangan G; Morrison J; Quigley M; Hunt JT; Salter-Cid L; Lees E; Sanjuan MA; Liu J
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408094
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent and selective HPK1 inhibitors based on the 2,4-disubstituted pyrimidine scaffold with immune modulatory properties for ameliorating T cell exhaustion.
Zeng S; Zeng M; Yuan S; He L; Jin Y; Huang J; Zhang M; Yang M; Pan Y; Wang Z; Chen Y; Xu X; Huang W
Bioorg Chem; 2023 Oct; 139():106728. PubMed ID: 37536217
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Qiu X; Liu R; Ling H; Zhou Y; Ren X; Zhou F; Zhang J; Huang W; Wang Z; Ding K
Eur J Med Chem; 2024 Apr; 269():116310. PubMed ID: 38479166
[TBL] [Abstract][Full Text] [Related]
13. The development of small-molecule inhibitors targeting HPK1.
Zhou L; Wang T; Zhang K; Zhang X; Jiang S
Eur J Med Chem; 2022 Dec; 244():114819. PubMed ID: 36209628
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of 2,4-diaminopyrimidine derivatives as potent Hematopoietic Progenitor Kinase 1 (HPK1) inhibitors.
Fu S; Wei J; Li C; Zhang N; Yue H; Yang A; Xu J; Dong K; Xing Y; Tong M; Shi X; Xi Z; Wang H; Hou Y; Zhao Y
Bioorg Chem; 2024 May; 148():107454. PubMed ID: 38795581
[TBL] [Abstract][Full Text] [Related]
15. HPK1 as a novel target for cancer immunotherapy.
Sawasdikosol S; Zha R; Yang B; Burakoff S
Immunol Res; 2012 Dec; 54(1-3):262-5. PubMed ID: 22477524
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Pharmacological Evaluation of Isoindoline Analogues as New HPK1 Inhibitors.
Xie C; Liu B; Song Z; Yang Y; Dai M; Gao Y; Yao Y; Ding C; Ai J; Zhang A
J Med Chem; 2023 Dec; 66(23):16201-16221. PubMed ID: 37990878
[TBL] [Abstract][Full Text] [Related]
17. Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.
Arnold R; Patzak IM; Neuhaus B; Vancauwenbergh S; Veillette A; Van Lint J; Kiefer F
Mol Cell Biol; 2005 Mar; 25(6):2364-83. PubMed ID: 15743830
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of immuno-oncology target HPK1 - a patent review (2016 to 2020).
Linney ID; Kaila N
Expert Opin Ther Pat; 2021 Oct; 31(10):893-910. PubMed ID: 33956554
[No Abstract] [Full Text] [Related]
19. The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function.
Hernandez S; Qing J; Thibodeau RH; Du X; Park S; Lee HM; Xu M; Oh S; Navarro A; Roose-Girma M; Newman RJ; Warming S; Nannini M; Sampath D; Kim JM; Grogan JL; Mellman I
Cell Rep; 2018 Oct; 25(1):80-94. PubMed ID: 30282040
[TBL] [Abstract][Full Text] [Related]
20. The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy.
Malchow S; Korepanova A; Panchal SC; McClure RA; Longenecker KL; Qiu W; Zhao H; Cheng M; Guo J; Klinge KL; Trusk P; Pratt SD; Li T; Kurnick MD; Duan L; Shoemaker AR; Gopalakrishnan SM; Warder SE; Shotwell JB; Lai A; Sun C; Osuma AT; Pappano WN
ACS Chem Biol; 2022 Mar; 17(3):556-566. PubMed ID: 35188729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
